Cue Biopharma Inc. (CUE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,677,666 $31,195 -1% 0.88%
2.
Corriente Advisors

Mark Hart Iii

1,486,986 $17,323 -42% 9.34%
3.
Slate Path Capital

David Greenspan

1,483,619 $17,284 0.96%
4. 704,220 $8,204 +109% 0.28%
5.
Woodline PartnersKarl

Michael Rockefeller And Kroeker

667,224 $7,773 +229% 0.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$15.07 2,720 Officer 4,720 2021-01-20 Filing
$12.64 6,548 Director 165,000 2020-11-24 Filing
$15.30 5,000 Director 677,500 2020-09-30 Filing
$15.00 5,000 Director 672,500 2020-09-29 Filing
$25.24 2,953 Director 158,452 2020-06-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$15.09 439 Officer 2,000 2021-03-16 Filing
$15.10 13,000 Officer 2,000 2021-03-15 Filing
$15.06 4,274 Officer 2,000 2021-02-17 Filing
$15.15 16,000 Officer 2,000 2021-02-16 Filing
$15.07 2,720 Officer 2,000 2021-01-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,148,798 $25,034 0%
2. 1,557,718 $18,147 0%
3. 1,470,075 $17,126 0%
4. 1,058 $12,326 0%
5. 516,319 $6,015 0%
News See All